{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Psychedelic-Assisted Therapy

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define the key elements of the administration of psychedelic-assisted therapy.
  2. Recognize the evidence that describes psychedelic-assisted therapy as a promising option for treating depression and other mental health issues.
  3. Identify ways that nurses can consider preparing for a role in psychedelic-assisted therapy.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: AJN0621
Published: June 2021
Expires: 6/2/2023
Required Passing Score: 7/10 (70%)
Authors: Andrew Penn, MS, NP, PMHNP-BC; Caroline G. Dorsen, PhD, FNP-BC; Stephanie Hope, DNP, RN, NC-BC; William E. Rosa, PhD, MBE, AGPCNP-BC, FAANP, FAAN